United Therapeutics (UTHR) Net Margin (2016 - 2025)
Historic Net Margin for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 42.36%.
- United Therapeutics' Net Margin rose 10900.0% to 42.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.33%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 41.53% for FY2024, which is 7800.0% down from last year.
- Per United Therapeutics' latest filing, its Net Margin stood at 42.36% for Q3 2025, which was up 10900.0% from 38.76% recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Net Margin ranged from a high of 21710.0% in Q4 2023 and a low of 3813.92% during Q4 2024
- For the 5-year period, United Therapeutics' Net Margin averaged around 975.68%, with its median value being 40.56% (2025).
- Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 216831200bps in 2023, then plummeted by -255239200bps in 2024.
- Over the past 5 years, United Therapeutics' Net Margin (Quarter) stood at 27.02% in 2021, then fell by -1bps to 26.88% in 2022, then surged by 80676bps to 21710.0% in 2023, then crashed by -118bps to 3813.92% in 2024, then skyrocketed by 101bps to 42.36% in 2025.
- Its last three reported values are 42.36% in Q3 2025, 38.76% for Q2 2025, and 40.56% during Q1 2025.